Halozyme Therapeutics Inc at JMP Securities Life Science Conference Transcript
All right, so we are going to go ahead and get started. Thank you again for joining us this afternoon at the JMP Securities Life Science Conference. The next company we have here to talk to us is Halozyme and the Company's CFO, Laurie Stelzer. So Laurie, thank you for being with us this afternoon.
Thank you, Jason. Thanks for having me.
Let me add my congratulations on the news you had very recently, a couple days ago, that you in the 301 study have had the last event to trigger the primary endpoint analysis. So we will get those data by the end of the year. So, great.
That's correct.
Maybe if we just start there and if you just want to give us a brief update on that announcement and on the trial progress
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
